These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 30048132)

  • 1. Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).
    Chien HC; Colas C; Finke K; Springer S; Stoner L; Zur AA; Venteicher B; Campbell J; Hall C; Flint A; Augustyn E; Hernandez C; Heeren N; Hansen L; Anthony A; Bauer J; Fotiadis D; Schlessinger A; Giacomini KM; Thomas AA
    J Med Chem; 2018 Aug; 61(16):7358-7373. PubMed ID: 30048132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Mutations and Ligands on the Thermostability of the l-Arginine/Agmatine Antiporter AdiC and Deduced Insights into Ligand-Binding of Human l-Type Amino Acid Transporters.
    Ilgü H; Jeckelmann JM; Colas C; Ucurum Z; Schlessinger A; Fotiadis D
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1.
    Singh N; Ecker GF
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptake.
    Kärkkäinen J; Gynther M; Kokkola T; Petsalo A; Auriola S; Lahtela-Kakkonen M; Laine K; Rautio J; Huttunen KM
    Int J Pharm; 2018 Jun; 544(1):91-99. PubMed ID: 29669256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1).
    Singh N; Villoutreix BO; Ecker GF
    Sci Rep; 2019 Oct; 9(1):15061. PubMed ID: 31636293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.
    Zur AA; Chien HC; Augustyn E; Flint A; Heeren N; Finke K; Hernandez C; Hansen L; Miller S; Lin L; Giacomini KM; Colas C; Schlessinger A; Thomas AA
    Bioorg Med Chem Lett; 2016 Oct; 26(20):5000-5006. PubMed ID: 27624080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs.
    Puris E; Gynther M; Huttunen J; Petsalo A; Huttunen KM
    J Control Release; 2017 Sep; 261():93-104. PubMed ID: 28662899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1).
    Ylikangas H; Malmioja K; Peura L; Gynther M; Nwachukwu EO; Leppänen J; Laine K; Rautio J; Lahtela-Kakkonen M; Huttunen KM; Poso A
    ChemMedChem; 2014 Dec; 9(12):2699-707. PubMed ID: 25205473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Prodrug Size and a Carbonyl Linker on l-Type Amino Acid Transporter 1-Targeted Cellular and Brain Uptake.
    Venteicher B; Merklin K; Ngo HX; Chien HC; Hutchinson K; Campbell J; Way H; Griffith J; Alvarado C; Chandra S; Hill E; Schlessinger A; Thomas AA
    ChemMedChem; 2021 Mar; 16(5):869-880. PubMed ID: 33230949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition.
    Uchino H; Kanai Y; Kim DK; Wempe MF; Chairoungdua A; Morimoto E; Anders MW; Endou H
    Mol Pharmacol; 2002 Apr; 61(4):729-37. PubMed ID: 11901210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
    Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
    Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.
    Lu X
    Curr Cancer Drug Targets; 2019; 19(11):863-876. PubMed ID: 31376820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion.
    Ylikangas H; Peura L; Malmioja K; Leppänen J; Laine K; Poso A; Lahtela-Kakkonen M; Rautio J
    Eur J Pharm Sci; 2013 Feb; 48(3):523-31. PubMed ID: 23228412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of LAT1 and LAT2 in the high- and low-affinity transport of L-leucine in human retinal pigment epithelial cells (ARPE-19 cells).
    Yamamoto A; Akanuma S; Tachikawa M; Hosoya K
    J Pharm Sci; 2010 May; 99(5):2475-82. PubMed ID: 19890975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutagenesis of rabbit LAT1 at amino acids 219 and 234.
    Boado RJ; Li JY; Pardridge WM
    J Neurochem; 2003 Mar; 84(6):1322-31. PubMed ID: 12614332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocation.
    Kärkkäinen J; Laitinen T; Markowicz-Piasecka M; Montaser A; Lehtonen M; Rautio J; Gynther M; Poso A; Huttunen KM
    Bioorg Chem; 2021 Jul; 112():104921. PubMed ID: 33933805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands.
    Huttunen J; Agami M; Tampio J; Montaser AB; Huttunen KM
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
    Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
    Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan.
    Hall C; Wolfe H; Wells A; Chien HC; Colas C; Schlessinger A; Giacomini KM; Thomas AA
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2254-2258. PubMed ID: 31248771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid ester prodrugs conjugated to the α-carboxylic acid group do not display affinity for the L-type amino acid transporter 1 (LAT1).
    Rautio J; Kärkkäinen J; Huttunen KM; Gynther M
    Eur J Pharm Sci; 2015 Jan; 66():36-40. PubMed ID: 25305508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.